Anthera PharmaceuticalsANTH
13F holders, Q4 2025 (December 31)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Anthera Pharmaceuticals Inc. (ANTH) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holder was Steigerwald, Gordon & Koch Inc. ($0).
- Company
- Anthera Pharmaceuticals Inc.
- CUSIP
- 03674U300
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Steigerwald, Gordon & Koch Inc. | 0.00% | No change | 25 | $0 |
"% of holder's portfolio" is ANTH's weight in each manager's 13F, not the share of Anthera Pharmaceuticals Inc. the manager owns.